MedPath

Intra-articular Pulsed Radiofrequency With Steroids Injection Versus Intra-articular Steroids Injection in Chronic Sacroiliac Joint Arthritis

Registration Number
NCT03564106
Lead Sponsor
Assiut University
Brief Summary

The sacroiliac joint is Located between the pelvis and base of the spine, the sacroiliac joints are strong, stable joints that allow for little movement. While these joints do not bend like a knuckle or knee, they are susceptible to degenerative arthritis. Sacroiliac joint pain is one of the most common causes of chronic low back pain, accounting for 10% to 27% of patients with chronic lower back pain. It is known to be caused by abnormal motion in this joint, namely, too much motion or too little motion. Patients with pain experience various degrees of pain in the low back, groin, buttock, or posterior thigh.

Detailed Description

The pain starts when the Sacroiliac joint gets inflamed. There are several reasons it could happen. It could be hurt when playing sports or if fall down.

Sometimes start hurting when the ligaments that hold the SI joint together are damaged, which may make the joint move abnormally. The pain associated with sacroiliitis most commonly occurs in the buttocks and lower back. It can also affect the legs, groin and even the feet.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • All patients must have chronic pain more than 6 months and have failed medical treatment.
Read More
Exclusion Criteria
  • Infection at the site of injection
  • Opioids addiction
  • Coagulopathy or another bleeding diathesis
  • Those who refuse to participate in the study
  • Ankylosing Spondylitis patients
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
group Aintraarticular radiofrequency + intraarticular methylprednisolonereceive intraarticular radiofrequency + methylprednisolone (30 mg)
group Cintraarticular methylprednisolonereceive intraarticular methylprednisolone (30 mg)
Primary Outcome Measures
NameTimeMethod
pain intensityup to 6 months

Numeric Rating Scale (NRS)

Secondary Outcome Measures
NameTimeMethod
Patient Impressionup to 6 months

Patient Global Impression of Change Scale (PGIC)

Pain Disabilityup to 6 months

Pain Disability Index ( PDI)

Trial Locations

Locations (1)

Assiut governorate

🇪🇬

Assiut, Egypt

© Copyright 2025. All Rights Reserved by MedPath